The dose should be upwardly adjusted weekly by 0.6 mg up to the target dose of 3 mg per day
10.1046/j.1471-4159.2000.0752611.x 206 TannerC
The insulin-like growth factor-binding protein superfamily
The majority of weight loss drug lawsuits filed claim that the companies failed to warn patients about the risk of delayed gastric emptying, severe gastroparesis, intestinal blockages, and vision loss, such as non-arteritic anterior ischemic optic neuropathy (NAION)
The design of this anchor trial matters immensely because it compares the combined mechanistic approach directly against a standard biologic therapy
Abnormal results in an organic acids test can indicate metabolic dysregulation, which may signal underlying issues such as nutrient deficiencies, gut dysbiosis, or more complex health conditions